ArticleFrontiers in nutrition2025
Acceptance and feasibility of novel staple foods among individuals with type 2 diabetes in Singapore: a mixed methods study.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Novel staple foods (NVSFs) are defined as modified staple foods that provide healthier alternatives to type 2 diabetes (T2D) patients aiming to improve postprandial glycemic responses. We explored the expectations and perceptions of participants with T2D toward NVSFs alongside their feasibility using a mixed methods approach. Methods: Three distinct NVSFs were investigated: (i) bread fortified with anthocyanins for carbohydrase inhibition; (ii) white rice fortified with fiber; and (iii) microfluidic gel noodles reduced in available carbohydrates. Sixteen individuals with T2D participated in a 5-week crossover study where NVSFs or control staple foods were consumed in mixed meals for breakfast, lunch, and dinner. Participants wore continuous glucose monitoring devices during interventions to measure postprandial glycemic responses and interviews were conducted before and after interventions. Results: Qualitative analysis from interviews identified participants' prior dietary choices, prior NVSF perceptions, expectations, and impressions, trade-offs between sensory and healthfulness, price, modification methods, and other socio-economic regular consumption considerations as key factors contributing to the acceptance of NVSFs. Among the NVSFs, the anthocyanin-fortified bread and fiber-fortified rice were preferred for their palatability, but not the microfluidic noodles. However, quantitative analysis from continuous glucose monitoring revealed only the microfluidic noodle meal demonstrating a significant reduction in 2-h iAUC value relative to its control from 160.2 ± 17.6 to 114.3 ± 12.2 mmol/L.min (mean ± SEM) Discussion: This highlights the challenge of attaining a balance between health and favorable sensory properties for these NVSFs, which may be attributed to their modification methods. We conclude that an alternative staple food with palatable taste and texture properties modified through the reduction of available carbohydrates may be an effective approach to enhance the acceptance and feasibility of modified staple foods for T2D management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.